Traitement Cancer de la thyroïde en Israël — recevez 3 correspondances personnalisées de cliniques

Thyroid cancer surgery in Israel includes total thyroidectomy, lobectomy, and advanced scarless techniques like transoral or robotic-assisted procedures. Specialized centers like Sourasky Medical Center (Ichilov) and Sheba Medical Center utilize intraoperative nerve monitoring. These JCI-accredited facilities maintain a 90% oncology success rate.

• Total thyroidectomy: Complete gland removal performed for advanced cases to prevent recurrence.
• Thyroid lobectomy: Removal of one lobe for slow-growing, isolated tumors under 1cm.
• Robotic surgery: Precise removal through small incisions using the Da Vinci robotic system.
• Transoral approach: Scarless surgery where the thyroid is removed through the lower lip.

Bookimed Expert Insight: While many global centers prioritize total removal, Israeli protocols at university hospitals like Hadassah and Sheba frequently favor hemithyroidectomy for microcarcinomas. This specific clinical preference helps patients preserve natural parathyroid function and often eliminates the need for lifelong hormone replacement therapy. This trend is backed by their high volume of over 34,000 annual operations.

Patient Consensus: Patients highlight that surgeries are often scheduled within weeks and emphasize the value of English-speaking surgeons. They note that nerve monitoring is standard to help preserve their voice.

Israel reports 5-year survival rates exceeding 90% for thyroid cancer patients. Papillary thyroid carcinoma, the most common type, shows a 95% survival rate. Advanced JCI-accredited centers utilize robotic thyroidectomy and radioactive iodine to maintain these high global benchmarks for early and regional stages.

• Success by type: Early-stage papillary and follicular cancers show 95% to 99% efficacy.
• Medullary cancer outlook: Localized cases typically maintain a 90% 10-year survival rate.
• Advanced treatment response: Radioactive iodine therapy reduces cancerous tissue in 95% of patients.
• Facility performance: Sourasky Medical Center reports an average 90% oncology treatment success rate.

Bookimed Expert Insight: Data shows a high concentration of Forbes-listed specialists, such as Dr. Aaron Popovcer at Hadassah Medical Center. This level of expertise is paired with massive patient volumes. Sheba Medical Center alone serves 2 million patients annually. This high frequency creates a cycle of refined surgical skill that directly contributes to the 98% success rate reported for robot-assisted procedures in top private clinics.

Patient Consensus: Patients note that while the cure rate for low-risk cases is exceptionally high, thyroidectomy requires lifelong medication adjustments. They emphasize seeking experienced surgeons like Dr. Avi Hefetz to ensure the best functional outcomes.

Israel's top hospitals for thyroid cancer include Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These JCI-accredited institutions utilize advanced diagnostics like PET/CT and specialized radioiodine therapy. Treatment plans often feature minimally invasive surgery. Expert multidisciplinary teams ensure high success rates for complex oncology cases.

• Sourasky Medical Center: Reports a 90% average success rate for oncology patients in Tel Aviv.
• Sheba Medical Center: Ranked among the world's best hospitals by Newsweek for consecutive years.
• Hadassah Medical Center: Home to the Sharett Institute, the first comprehensive cancer center in Israel.
• Assuta Medical Center: This leading private facility offers patients their choice of attending surgeons.

Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba manage massive patient volumes, exceeding 1.8 million annually. This high frequency allows surgeons like Dr. Avi Hefetz or Prof. Dan Fliss to maintain exceptional technical proficiency. Patients should prioritize clinics with integrated nuclear medicine departments to streamline post-surgical radioiodine therapy.

Patient Consensus: Patients note that robotic-assisted surgery in Israel can significantly reduce recovery time compared to traditional methods. Many emphasize booking ENT surgeons early because specialized schedules for international travelers fill up very quickly.

Patients should ask Israeli surgeons about their annual thyroid cancer case volume and specific rates of vocal cord nerve preservation. Inquiries must cover the rationale for choosing a total thyroidectomy over a lobectomy. Confirming radioactive iodine protocols and long-term thyroglobulin surveillance schedules is essential for recovery.

• Surgical volume: Ask specifically about thyroid cancer cases, aiming for 25 to 50 annually.
• Nerve protection: Verify if the surgeon uses advanced intraoperative nerve monitoring for vocal cords.
• Pathology governance: Request a written rationale for the chosen extent of tissue or node removal.
• Hormone management: Clarify which endocrinologist will manage TSH suppression protocols and levothyroxine dosages.
• Ablation timing: Establish the threshold and timeline for radioactive iodine therapy before the procedure.

Bookimed Expert Insight: Israeli centers like Sourasky or Hadassah often involve university-affiliated specialists who appear on Forbes best lists. Data shows these high-volume facilities manage over 1,000,000 patients yearly. This scale allows surgeons to specialize strictly in oncology rather than general ENT cases. This specialization is a key factor in achieving 90% success rates in complex cancer care.

Patient Consensus: Patients note it is critical to confirm the follow-up plan for thyroglobulin monitoring and ultrasounds early. They also emphasize getting a second opinion from a major cancer center before committing to surgery.